CRIS Current Research Information System

RICCI, CHIARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 3.720
NA - Nord America 3.593
EU - Europa 2.385
SA - Sud America 283
Continente sconosciuto - Info sul continente non disponibili 178
AF - Africa 116
OC - Oceania 12
Totale 10.287
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.498
VN - Vietnam 1.116
SG - Singapore 1.075
IT - Italia 1.002
CN - Cina 775
HK - Hong Kong 387
GB - Regno Unito 308
BR - Brasile 208
DE - Germania 184
SE - Svezia 167
FR - Francia 140
NL - Olanda 118
RU - Federazione Russa 100
IN - India 90
UA - Ucraina 81
FI - Finlandia 66
CA - Canada 53
IE - Irlanda 52
BG - Bulgaria 49
JP - Giappone 38
BD - Bangladesh 35
ZA - Sudafrica 34
CI - Costa d'Avorio 31
AR - Argentina 28
JO - Giordania 26
ID - Indonesia 25
SC - Seychelles 23
TH - Thailandia 23
PH - Filippine 22
EE - Estonia 20
KR - Corea 20
IQ - Iraq 17
CH - Svizzera 16
MX - Messico 15
PL - Polonia 15
BE - Belgio 13
AU - Australia 12
TG - Togo 12
EC - Ecuador 11
ES - Italia 11
CO - Colombia 10
MY - Malesia 10
PK - Pakistan 10
SA - Arabia Saudita 10
GR - Grecia 9
LT - Lituania 7
TR - Turchia 7
TW - Taiwan 7
AT - Austria 6
CR - Costa Rica 5
CZ - Repubblica Ceca 5
PE - Perù 5
PY - Paraguay 5
VE - Venezuela 5
CL - Cile 4
DO - Repubblica Dominicana 4
GT - Guatemala 4
IR - Iran 4
JM - Giamaica 4
KE - Kenya 4
NP - Nepal 4
UZ - Uzbekistan 4
AE - Emirati Arabi Uniti 3
BO - Bolivia 3
LU - Lussemburgo 3
PS - Palestinian Territory 3
PT - Portogallo 3
TN - Tunisia 3
UY - Uruguay 3
AG - Antigua e Barbuda 2
BB - Barbados 2
BS - Bahamas 2
CG - Congo 2
DK - Danimarca 2
IL - Israele 2
NI - Nicaragua 2
RO - Romania 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BH - Bahrain 1
BM - Bermuda 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
DZ - Algeria 1
EG - Egitto 1
GH - Ghana 1
HN - Honduras 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
LV - Lettonia 1
MA - Marocco 1
MN - Mongolia 1
MT - Malta 1
MU - Mauritius 1
RE - Reunion 1
RS - Serbia 1
SI - Slovenia 1
Totale 10.109
Salva come PNG Salva come JPEG
Città #
Singapore 656
San Jose 367
Hong Kong 365
Ashburn 343
Santa Clara 305
Ho Chi Minh City 286
Hanoi 257
Southend 252
Chandler 180
Fairfield 150
Boardman 141
Beijing 130
Milan 99
Council Bluffs 95
Rome 79
Wilmington 76
Bologna 74
Woodbridge 72
Ann Arbor 69
Princeton 69
Seattle 68
New York 63
Helsinki 62
Houston 60
Los Angeles 59
Dublin 52
Sofia 49
Cambridge 47
Jacksonville 45
Dong Ket 44
Da Nang 39
Dallas 39
Nanjing 37
Lauterbourg 35
Padova 35
Haiphong 34
Hefei 33
Abidjan 31
Westminster 29
Jinan 28
Tokyo 28
Buffalo 27
Amman 26
Turin 23
Berlin 22
Frankfurt am Main 22
Naples 22
Shanghai 22
Chicago 21
Falkenstein 21
Orem 20
Hải Dương 19
Phoenix 19
San Francisco 19
Bari 18
Florence 17
Mountain View 17
Shenyang 17
São Paulo 17
Biên Hòa 16
Verona 16
Can Tho 15
Guangzhou 15
Saint Petersburg 15
Montreal 13
Nanchang 13
Tianjin 13
Lomé 12
Warsaw 12
Atlanta 11
Bangkok 11
Brescia 11
Brussels 11
Changsha 11
Chennai 11
Denver 11
Redondo Beach 11
Sydney 11
Catania 10
Mülheim 10
San Diego 10
Thái Nguyên 10
Toronto 10
Amsterdam 9
Ha Long 9
Brooklyn 8
Fort Worth 8
Manchester 8
Parma 8
Seoul 8
Shenzhen 8
Vũng Tàu 8
Zhengzhou 8
Baghdad 7
Bắc Giang 7
Jakarta 7
London 7
Ninh Bình 7
Ottawa 7
Porto Alegre 7
Totale 5.771
Salva come PNG Salva come JPEG
Nome #
Ruolo dei batteri componenti la flora intestinale nell’eziopatogenesi della colite ulcerosa e del cancro del colon: i Fusobatteri e il Bacteroides fragili enterotossico prendono la scena. 610
Sequenze genomiche dei batteri filamentosi segmentati negli animali da laboratorio. Implicazioni per la ricerca sull’uomo 393
Dietary geraniol ameliorates intestinal dysbiosis and relieves symptoms in irritable bowel syndrome patients: a pilot study. 326
Dietary geraniol by oral or enema administration strongly reduces dysbiosis and systemic inflammation in dextran sulfate sodium-treated mice 240
Accuracy of breath tests using low doses of 13C-urea to diagnose Helicobacter pylori infection: a randomised controlled trial 233
Review article: Invasive and non-invasive tests for Helicobacter pylori infection 232
Accuracy of a new ultra fast rapid urease test to diagnose Helicobacter pylori infection in 1000 consecutive patients 226
Epidemiologia dell’Infezione da Helicobacter pylori e Cancro gastrico non cardiale. Insegnamenti per il futuro. 218
A 10 days levofloxacin base triple therapy in patients who failed two eradication courses 210
Diagnosi non invasiva e terapia per Helicobacter Pylori 209
Effect of Proton Pump Inhibitors and Antacid Therapy on 13C-Urea Breath Tests and Stool Test for Helicobacter pylori Infection 203
A Rapid Immunochromatographic Assay for Helicobacter pylori in Stool before and after Treatment 201
Levofloxacin-based triple therapy for Helicobacter pylori retreatment: role of bacterial resistance. 198
E-test for Metronidazole Susceptibility Q1 in H pylori: Use of the Wrong Standard May Have Led to the Wrong Conclusion: Reply 194
Gastroesophageal Reflux Disease and Barrett’s Esophagus 191
Post COVID-19 irritable bowel syndrome 186
Diagnosi dell’infezione da Helicobacter pylori 181
Primary antibiotic resistance in Helicobacter pylori strains isolated in Northern and Central Italy. 165
How to proceed in H pylori-positive chronic gastritis refractory to first and second line eradication therapy. 164
Peptic ulcer and Helicobacter pylori. 161
Diagnosis of Helicobacter pylori: invasive and non- invasive tests 160
Sequential therapy or triple therapy for Helicobacter pylori infection: systematic review and Meta-analysis of randomized controlled trials in adults and children. 158
Probiotici ricombinanti e loro potenziale sulla salute umana 153
Le molecole strutturali batteriche come potenziali candidate per l’evoluzione del concetto classico di probiotici. 147
Recombinant probiotics and their potential in human health 145
High Helicobacter pylori eradication with sequential therapy in elderly patients with peptic ulcer: a prospective controlled study 144
Valutazione di economia sanitaria sull’infezione da Helicobacter pylori. 137
Best Cut-Off Values for [14C]-Urea Breath Tests for Helicobacter pylori Detection 134
The stool antigen test for detection of Helicobacter pylori after eradication therapy 133
Infezione da Helicobacter pylori: Le nuove indicazioni terapeutiche in Italia 122
Sequential therapy versus Triple Therapy for Helicobacter pylori Eradication: a randomized trial 116
Ruolo della radiologia interventistica nelle complicanze dopo resezione pancreatica 105
Long-Term Impact of COVID-19 on Disorders of Gut–Brain Interaction: Incidence, Symptom Burden, and Psychological Comorbidities 95
Newer agents for Helicobacter pylori eradication 93
null 83
Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication: A randomized trial 79
Rifaximin suspension for the eradication of helicobacter pylori 79
The clinical role of stool test (HpSA) in noninvasive diagnosis of Helicobacter pylori infection 76
Helicobacter pylori in Patients with Gastric and Nongastric Cancer 73
Non-invasive analyses for the diagnosis of Helicobacter pylori infection. A critical review of the literature 71
Diagnostic accuracy of a new rapid urease test (Pronto Dry) before and after treatment of Helicobacter pylori infection 70
The clinical role of cytochrome P450 genotypes in Helicobacter pylori management 66
Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication: A randomized trial 65
A rapid, low-dose, 13C-urea tablet for the detection of Helicobacter pylori infection before and after treatment 64
Non-invasive analyses for the diagnosis of Helicobacter pylori infection. A critical review of the literature 62
Rifaximin suspension for the eradication of helicobacter pylori 62
Best Cut-Off Values for [14C]-Urea Breath Tests for Helicobacter pylori Detection 62
Antimicrobial activity of esomeprazole versus omeprazole against Helicobacter pylori 60
Helicobacter pylori in Patients with Gastric and Nongastric Cancer 60
Review article: The transmission of Helicobacter pylori from stomach to stomach 59
New immunological assays for the diagnosis of Helicobacter pylori infection 59
Peptic ulcer and Helicobacter pylori: Update on testing and treatment 58
The clinical role of cytochrome P450 genotypes in Helicobacter pylori management 57
Diagnosis of Helicobacter pylori infection: Which is the best test? The stool test 57
Peptic ulcer and Helicobacter pylori: Update on testing and treatment 55
The clinical role of stool test (HpSA) in noninvasive diagnosis of Helicobacter pylori infection 54
High eradication rates of Helicobacter pylori with a new sequential treatment 53
A new treatment protocol for Helicobacter pylori infection: Preliminary results of a prospective, multicentric and randomized study 53
Review article: The transmission of Helicobacter pylori from stomach to stomach 53
The stool antigen test for detection of Helicobacter pylori after eradication therapy 53
High eradication rates of Helicobacter pylori with a new sequential treatment 53
Helicobacter pylori status, endoscopic findings, and serology in HIV-1-positive patients 51
Helicobacter pylori infection: Anything new should we know? 50
Helicobacter pylori, diagnosis and treatment after 10 years of its discovery 49
New immunological assays for the diagnosis of Helicobacter pylori infection 48
Accurate diagnosis of helicobacter pylori stool tests 48
Peptic ulcer and Helicobacter pylori 47
A new treatment protocol for Helicobacter pylori infection: Preliminary results of a prospective, multicentric and randomized study 46
Helicobacter pylori status, endoscopic findings, and serology in HIV-1-positive patients 46
Serological response to Helicobacter pylori in gastric and non-gastric cancer 45
Helicobacter pylori infection: Anything new should we know? 43
Accuracy of the stool antigen test in the diagnosis of Helicobacter pylori infection before treatment and in patients on omeprazole therapy 42
Esophagitis and gastroesophageal reflux 42
Helicobacter pylori, diagnosis and treatment after 10 years of its discovery 42
Accuracy of stool antigen test in posteradication assessment of Helicobacter priori infection 42
Review article: Invasive and non-invasive tests for Helicobacter pylori infection 41
Review article: Diagnosis and treatment of Helicobacter: A 2002 updated review 41
Accurate diagnosis of helicobacter pylori stool tests 41
Diagnostic accuracy of a new rapid urease test (Pronto Dry) before and after treatment of Helicobacter pylori infection 40
Accuracy of the stool antigen test in the diagnosis of Helicobacter pylori infection before treatment and in patients on omeprazole therapy 39
Accuracy of stool antigen test in posteradication assessment of Helicobacter priori infection 38
Therapeutics news on Helicobacter pylori and clarithromycin from Budapest, Wien and Helsinki 38
Susceptibility of Helicobacter pylori to Metronidazole 38
Blood tests in the management of Helicobacter pylori infection 36
Review article: Helicobacter pylori infection from pathogenesis to treatment - A critical reappraisal 36
Review article: Helicobacter pylori infection from pathogenesis to treatment - A critical reappraisal 35
Review article: Diagnosis of Helicobacter pylori infection 35
Blood tests in the management of Helicobacter pylori infection 35
Esophagitis and gastroesophageal reflux 35
Effect of Helicobacter pylori eradication on development of dyspeptic and reflux disease in healthy asymptomatic subjects 34
Effect of Helicobacter pylori eradication on development of dyspeptic and reflux disease in healthy asymptomatic subjects 33
Susceptibility of Helicobacter pylori to Metronidazole 32
Routes of trasmission of Helicobacter pylori infection 32
Review article: Diagnosis and treatment of Helicobacter: A 2002 updated review 31
A second-line anti-Helicobacter pylori therapy in patients with previously failed treatment [7] 31
A rapid, low-dose, 13C-urea tablet for the detection of Helicobacter pylori infection before and after treatment 30
Clinical significance of helicobacter pylori seropositivity and seronegativity in asymptomatic blood donors 30
A second-line anti-Helicobacter pylori therapy in patients with previously failed treatment [7] 29
Absence of Helicobacter pylori in dental plaque assessed by stool test [19] 27
Anti-CagA reactivity in Helicobacter pylori-negative subjects: A comparison of three different methods 27
Totale 9.784
Salva come PNG Salva come JPEG
Categoria #
all - tutte 30.469
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.469
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022617 0 17 34 74 61 25 9 36 21 22 212 106
2022/2023699 72 97 59 81 30 61 23 34 138 16 56 32
2023/2024717 144 63 49 108 60 110 42 15 18 35 39 34
2024/20252.228 92 246 126 148 541 146 155 100 48 116 41 469
2025/20264.135 452 229 339 293 436 217 300 360 792 356 140 221
2026/2027408 211 197 0 0 0 0 0 0 0 0 0 0
Totale 10.287